Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.64
0.12 (0.68%)
At close: Aug 14, 2025, 3:59 PM
17.76
0.68%
Pre-market: Aug 15, 2025, 09:17 AM EDT

Beam Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-102.29M -109.27M -90.35M -96.67M -91.05M -98.67M 142.8M -96.09M -82.78M -96.46M -38.35M -109.58M -71.95M -69.21M -64.71M -28.12M -76.25M -201.56M
Depreciation & Amortization
-2.93M 5.53M 15.11M 5.47M 5.58M 5.43M 5.36M 5.19M 4.82M 4.65M 3.94M 3.47M 3.42M 3.31M 2.63M 1.75M 1.67M 1.4M
Stock-Based Compensation
24.37M 26.68M 30.22M 29.56M 31.6M 29.28M 22.62M 25.84M 26.28M 23.92M 22.5M 22.21M 21.58M 18.04M 15.5M 12.97M 10.45M 4.65M
Other Working Capital
29.27M -29.27M -20.2M -24.9M -27.68M -39.25M -29.6M -16.6M -17.94M -44.6M -13.25M -15.8M 1.14M 272.37M 42.8M 57.52M 11.07M -954K
Other Non-Cash Items
-21.07M -1.35M -10.59M -894K 37.76M 41.03M 31.06M -3.71M 304K 2.92M -46.93M 3.02M -6.56M -4.76M 6.62M -8.45M 4.05M 156.64M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -35.26M -1.36M -12.82M n/a n/a n/a n/a n/a -3.18M -30.93M 15.43M 1.92M
Change in Working Capital
25.47M -25.47M -20.75M -25.6M -25.91M -37.96M -31.51M -19.64M -20.47M -44.83M -10.35M -10.37M 1.24M 271.11M 44.96M 55.79M 12.12M -1.62M
Operating Cash Flow
-76.45M -103.88M -76.36M -88.13M -83.01M -99.75M 135.07M -89.78M -84.67M -109.81M -69.19M -74.5M -52.28M 218.49M 1.83M 3.01M -32.53M -38.58M
Capital Expenditures
-3.14M -3.06M -2.97M -1.58M -1.96M -2.44M -3.59M -7.95M -16.18M -6.02M -8.26M -11.79M -21.64M -7.26M -13.37M -5.78M -16.18M -11.48M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -101.69M 2.28M 25.3M -31.47M -121.7M n/a -20.38M n/a -620K n/a n/a 620K
Purchase of Investments
-333.94M -339.17M n/a -156.72M -134.47M -195.24M -53.27M -273.71M -390.83M -266.53M -238.39M -358.03M -330.19M -690.39M -170.48M -178.5M -139.03M -289.22M
Sales Maturities Of Investments
166.67M 217.15M 129.25M 183M 223.93M 144.22M 154.96M 271.43M 365.52M 298M 360.09M 333.64M 350.57M 160.31M 106.35M 260.39M 142.07M 20.45M
Other Investing Acitivies
n/a n/a n/a n/a 89.45M -51.03M 101.69M -2.28M -25.3M 31.47M 121.7M -24.39M 20.38M -530.08M 620K 81.89M 3.05M -268.77M
Investing Cash Flow
-170.41M -125.09M 126.28M 24.7M 87.49M -53.46M 98.1M -10.23M -41.48M 25.45M 113.44M -36.17M -1.26M -537.34M -77.5M 76.11M -13.14M -279.63M
Debt Repayment
n/a n/a n/a -201K -107K -177K -632K -400K -617K -603K -590K -579K -565K -553K -542K -530K -517K -529K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
470.77M 2.22M 3.44M n/a 240K 3.07M 745K 2.23M 517K 5.04M 3.79M 2.14M 543K 2.23M 1.84M 2.49M 2.67M -6.2M
Financial Cash Flow
1.11M 473.38M 3.44M 1.26M 133K 2.9M 33.71M 36.78M 107.54M 98.42M 32.01M 1.56M 22.34M 55.68M 21.54M 320.89M 160.44M 253.27M
Net Cash Flow
-245.75M 244.41M 53.36M -56.01M 4.92M -148.05M 266.85M -63.24M -18.61M 14.05M 76.26M -109.11M -31.2M -263.17M -54.12M 400.01M 114.77M -64.93M
Free Cash Flow
-79.59M -106.95M -79.33M -89.7M -84.97M -102.19M 131.48M -97.73M -100.85M -115.83M -77.45M -86.28M -73.92M 211.23M -11.54M -2.77M -48.71M -50.06M